Streetbeat News

Stock Prices

COOP

Mr. Cooper Group (NYSE:COOP) has seen a 3.77% increase in short interest, with 1.46 million shares sold short, representing 3.3% of its float. This is below the peer group average of 8.63%. The rise in short interest may indicate bearish sentiment, but it doesn't guarantee a price drop.

Portfolio Pulse from Benzinga Insights

September 06, 2024 | 1:45 pm

EME

EMCOR Group (NYSE:EME) has seen a 17.27% increase in short interest, with 1.05 million shares sold short, representing 2.92% of its float. This is below the peer group average of 5.11%. The rise in short interest may indicate bearish sentiment, but it doesn't guarantee a price drop.

Portfolio Pulse from Benzinga Insights

September 06, 2024 | 1:45 pm

FRPT

Freshpet's short interest has increased by 13.43%, with 12.5% of its float sold short. This is significantly higher than its peers' average of 3.78%. It would take 6.22 days to cover these positions based on current trading volume.

Portfolio Pulse from Benzinga Insights

September 06, 2024 | 1:45 pm

CRRSF

TXT

Cirrus Aircraft, a U.S.-based private jet maker, reported strong half-year earnings with a 12% revenue increase and a 24% profit jump. However, its stock price remains under pressure due to concerns over its Chinese ownership and potential U.S. sanctions. Despite robust demand and expansion plans, Cirrus trades at a discount compared to peers like Textron.

Portfolio Pulse from The Bamboo Works

September 06, 2024 | 1:40 pm

PL

Planet Labs PBC reported Q2 results with revenue missing expectations, leading to a 13.1% drop in share price. Analysts revised their price targets, with Needham lowering from $7 to $5 and Craig-Hallum raising from $2 to $2.5.

Portfolio Pulse from Avi Kapoor

September 06, 2024 | 1:37 pm

PFE

VOR

Vor Biopharma Inc. (NASDAQ:VOR) announced promising clinical data from its Phase 1/2 VBP101 study for treating acute myeloid leukemia (AML) with trem-cel and Pfizer's Mylotarg. The data showed reliable engraftment and early patient benefits, leading to a 28.5% increase in VOR's stock price. Vor Bio plans to discuss a pivotal trial with the FDA and has announced a new preclinical asset, VADC45.

Portfolio Pulse from Vandana Singh

September 06, 2024 | 1:35 pm

SPY

The Federal Reserve's John Williams stated that lowering interest rates is aimed at maintaining a balanced job market. He believes the current monetary policy is well-positioned to achieve the Fed's goals.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 1:30 pm

DAVA

EPAM

GLOB

JPMorgan has identified Endava Plc (NYSE:DAVA) as a 'top pick' in the IT services sector, projecting over 50% upside due to its strong position in digital transformation. Despite macroeconomic concerns, Endava's growth prospects in high-demand sectors like payments and telecoms make it a promising investment.

Portfolio Pulse from Surbhi Jain

September 06, 2024 | 1:28 pm

LKNCY

NYKHF

Nayuki Holdings Ltd. (OTC:NYKHF) reported a net loss in the first half of the year due to declining sales per store and increased costs, amidst intense competition in China's bubble tea market. The company's stock is valued lower than its peers, and it faces challenges from larger competitors using a franchise model.

Portfolio Pulse from The Bamboo Works

September 06, 2024 | 1:28 pm

SPY

Federal Reserve's John Williams stated that while progress is being made towards the 2% inflation target, the goal has not yet been achieved. This suggests that the Fed may continue its current monetary policy stance.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 1:28 pm